Stock screenerAll disclosures →
EDGAR →
BLFS
Conviction 88HealthcareScan · Thu, Sep 24, 2026Bullish engulfing
Biolife Solutions Inc (BLFS) closed at $38.58 (+2.23%) on Sep 24, 2026. Its latest daily candle is a bullish engulfing. Price is above its 50-day and above its 200-day moving average. RSI(14) 70, RS Rating 94, at a 52-week high, +61.5% year to date. Sector: Healthcare · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
BLFS$38.58+2.23%
ResistanceSupportVol 14Insider sellVol MA14 906.95K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price38.58
Change+2.23%
Gap-0.04%
Rel volume1.41×
Avg volume941.65K
Avg $ vol34.25M
SMA 2036.30
SMA 5034.52
SMA 20026.14
Price vs 50+11.76%
Price vs 200+47.57%
MA stackbullish
50/200 cross—
Supertrendup · 35.43
RSI (14)70
MACD hist0.14
MACD crossbull · 2d
Stoch %K / %D93 / 91
ADX (14)43
+DI / −DI32 / 10
RSI divergence—
MACD divergenceBearish
ATR %2.53%
ADR %2.57%
52w high38.58
52w low18.15
From 52w high+0.00%
Above 52w low+112.56%
New 52w highYes
SqueezeOff
Bollinger width11.77%
%B1.03
Donchian pos93.13%
Donchian high38.89
Donchian low34.38
AVWAP (52w high)38.40
vs AVWAP high+0.47%
AVWAP (52w low)29.19
vs AVWAP low+32.18%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d1.41×
Avg vol (14d)906.95K
Avg vol (20d)941.65K
Avg $ vol (20d)34.25M
Market cap1.89B
RS Rating94 / 99
RS 3m (vs SPY)+35.80%
RS 6m (vs SPY)+77.44%
RS line new highYes
Trend template8/8
Technical rank95.1
1 week+4.69%
1 month+3.65%
3 months+40.29%
6 months+94.26%
1 year+55.88%
YTD+61.49%
P/E-410.62
P/B4.49
P/S304.78
P/FCF177.38
EPS-0.1000
Div yield—
ROE-1.09%
ROA-1.03%
Debt/Eq0.00
Current9.69
EV/EBITDA-129.82
Gross margin—
Net margin-74.22%
Rev growth-30.83%
EPS growth77.23%
Price target31.00
Target upside-19.65%
Analyst ratingHold
Institutional107.88%
Ent. value1.86B
Revenue1.24M
Net income45.1M
Gross profit18.29M
Free cash flow10.64M
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
ExchangeNasdaq
Shares out48.86M
Employees155
ListedWed, Nov 22, 1989
Free float46.97M
Float %97.2%
Short interest3.93M
Days to cover4.8d
Short volume32.0%
Squeeze score47 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.04 vs −$0.01
Last surprise+500.0% beat
Setup gradeA+
Conviction88 / 100
Pattern quality—
Tech rank95.1 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- BioLife Solutions (NASDAQ:BLFS) Rating Lowered to Hold at Zacks ResearchMarketBeat · Wed, Sep 23, 2026
- Form 4 BioLife Solutions Inc For: 23 September By Investing.comInvesting.com UK · Wed, Sep 23, 2026
- BioLife Solutions (BLFS) withholds 564 insider shares for taxesStock Titan · Tue, Sep 22, 2026
- BioLife Solutions (BLFS) CTO sees 421 shares withheld for taxesStock Titan · Tue, Sep 22, 2026
- BioLife Solutions (BLFS) CEO uses shares to cover taxesStock Titan · Tue, Sep 22, 2026
- BioLife Solutions (NASDAQ:BLFS) Sets New 52-Week High - Here's What HappenedMarketBeat · Tue, Sep 22, 2026
- Biolife Solutions stock hits 52-week high at $38.10Investing.com · Tue, Sep 22, 2026
- BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Healthcare Innovation with Upside Potentialdirectorstalkinterviews.com · Tue, Sep 22, 2026
- Tidal Investments LLC Buys Shares of 29,012 BioLife Solutions, Inc. $BLFSMarketBeat · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in BLFS
No recent disclosed trades by Congress in BLFS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BLFS
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mathew Aby J. EVP & Chief Scientific Officer · Common Stock · 2026-07-07 | Tax | 516 | $14K | 2026-07-07 | 2026-07-13 |
Berard Todd Chief Marketing Officer · Common Stock · 2026-07-07 | Tax | 293 | $8K | 2026-07-07 | 2026-07-13 |
Wichterman Troy Chief Financial Officer · Common Stock · 2026-07-07 | Tax | 844 | $23K | 2026-07-07 | 2026-07-13 |
DE GREEF RODERICK President and CEO · Common Stock · 2026-06-18 | Tax | 2.77K | $72K | 2026-06-18 | 2026-06-22 |
Mathew Aby J. EVP & Chief Scientific Officer · Common Stock · 2026-06-18 | Tax | 564 | $15K | 2026-06-18 | 2026-06-22 |
Wichterman Troy Chief Financial Officer · Common Stock · 2026-06-18 | Tax | 937 | $24K | 2026-06-18 | 2026-06-22 |
Werner Sean Chief Technology Officer · Common Stock · 2026-06-18 | Tax | 420 | $11K | 2026-06-18 | 2026-06-22 |
Berard Todd Chief Marketing Officer · Common Stock · 2026-06-18 | Tax | 470 | $12K | 2026-06-18 | 2026-06-22 |
Mathew Aby J. EVP & Chief Scientific Officer · Common Stock · 2026-06-08 | Tax | 627 | $16K | 2026-06-08 | 2026-06-10 |
Berard Todd Chief Marketing Officer · Common Stock · 2026-06-08 | Tax | 356 | $9K | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in BLFS · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.